Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes

Despite low prevalence of methicillin-resistant Staphylococcus aureus (MRSA; 0.7%), nearly one-third of adults hospitalized with community-acquired pneumonia (CAP) received anti-MRSA antibiotics. Characteristics of MRSA and pneumococcal CAP overlapped substantially, highlighting the challenge of accurately targeting anti-MRSA antibiotics using clinical criteria.

[1]  W. Self,et al.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. , 2015, The New England journal of medicine.

[2]  W. Self,et al.  Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia. , 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[3]  James H. Jorgensen,et al.  Manual of Clinical Microbiology, 11th Edition , 2015 .

[4]  W. Boersma,et al.  Antibiotic treatment strategies for community-acquired pneumonia in adults. , 2015, The New England journal of medicine.

[5]  S. Saint,et al.  Why does antimicrobial overuse in hospitalized patients persist? , 2014, JAMA internal medicine.

[6]  R. Fagan,et al.  Vital Signs: Improving Antibiotic Use Among Hospitalized Patients , 2014, MMWR. Morbidity and mortality weekly report.

[7]  L. May,et al.  Better Tests, Better Care: Improved Diagnostics for Infectious Diseases , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Niederman,et al.  A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  H. Saka,et al.  Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. , 2013, American journal of respiratory and critical care medicine.

[10]  G. Taylor,et al.  Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals , 2013, PloS one.

[11]  E. Y. Kim,et al.  Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia , 2013, BMC Infectious Diseases.

[12]  M. Kollef,et al.  A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia , 2013, BMC Infectious Diseases.

[13]  B. Levine,et al.  Prescribing habits of vancomycin in the Emergency Department: are we dosing appropriately? , 2013, The Journal of emergency medicine.

[14]  P. Szilagyi,et al.  Field evaluation of TaqMan Array Card (TAC) for the simultaneous detection of multiple respiratory viruses in children with acute respiratory infection , 2013, Journal of Clinical Virology.

[15]  T. Wiemken,et al.  Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia , 2013, Infection.

[16]  D. Musher,et al.  Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study , 2013, Journal of Infection.

[17]  Kirk M. Ririe,et al.  Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. , 2012, Diagnostic microbiology and infectious disease.

[18]  R. Breiman,et al.  Additional Diagnostic Yield of Adding Serology to PCR in Diagnosing Viral Acute Respiratory Infections in Kenyan Patients 5 Years of Age and Older , 2012, Clinical and Vaccine Immunology.

[19]  B. Limbago,et al.  Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Mandell,et al.  Methicillin-Resistant Staphylococcus aureus and Community-Acquired Pneumonia: An Evolving Relationship , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  M. Mantero,et al.  Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Xiyan Xu,et al.  Serology as an adjunct to polymerase chain reaction assays for surveillance of acute respiratory virus infections. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  M. Kollef,et al.  Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  C. Byington,et al.  Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema , 2011, The Pediatric infectious disease journal.

[25]  J. Winchell,et al.  Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay☆ , 2011, Diagnostic Microbiology and Infectious Disease.

[26]  Leonard Leibovici,et al.  Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis , 2010, Antimicrobial Agents and Chemotherapy.

[27]  R. Wunderink,et al.  Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. , 2010, Chest.

[28]  Philip M Polgreen,et al.  Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. , 2009, Annals of emergency medicine.

[29]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[30]  P. Sawanpanyalert,et al.  Human Coronavirus Infections in Rural Thailand: A Comprehensive Study Using Real-Time Reverse-Transcription Polymerase Chain Reaction Assays , 2007, The Journal of infectious diseases.

[31]  P. Vanhems,et al.  Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  A. Steigerwalt,et al.  Evaluation and Improvement of Real-Time PCR Assays Targeting lytA, ply, and psaA Genes for Detection of Pneumococcal DNA , 2007, Journal of Clinical Microbiology.

[33]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  R. Wunderink.  Healthcare-associated bacteremia: Stirring the mud. , 2006, Critical care medicine.

[35]  V. Yu,et al.  A new category — healthcare-associated pneumonia: a good idea, but problems with its execution , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[36]  C. Bridges,et al.  Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season , 2006, Emerging infectious diseases.

[37]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[38]  M. Kollef,et al.  Staphylococcus aureus pneumonia: a "superbug" infection in community and hospital settings. , 2005, Chest.

[39]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[40]  D. Murdoch.  DIAGNOSIS OF LEGIONELLA INFECTION , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  D. Murdoch,et al.  Evaluation of a Rapid Immunochromatographic Test for Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired Pneumonia , 2001, Journal of Clinical Microbiology.

[42]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[43]  Henry D. Isenberg,et al.  Manual of Clinical Microbiology , 1991 .

[44]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[45]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[46]  L. Brammer,et al.  Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. , 2007, MMWR. Morbidity and mortality weekly report.

[47]  About Jama,et al.  Severe Methicillin-Resistant Staphylococcus aureus Community-Acquired Pneumonia Associated With Influenza— Louisiana and Georgia, December 2006-January 2007 , 2007 .

[48]  Mian Cai,et al.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[50]  R. Bartlett.  Medical microbiology: quality cost and clinical relevance , 1974 .